These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1361741)
1. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate. Aziz TZ; Peggs D; Agarwal E; Sambrook MA; Crossman AR Br J Neurosurg; 1992; 6(6):575-82. PubMed ID: 1361741 [TBL] [Abstract][Full Text] [Related]
2. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Aziz TZ; Peggs D; Sambrook MA; Crossman AR Mov Disord; 1991; 6(4):288-92. PubMed ID: 1758446 [TBL] [Abstract][Full Text] [Related]
3. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Mitchell IJ; Clarke CE; Boyce S; Robertson RG; Peggs D; Sambrook MA; Crossman AR Neuroscience; 1989; 32(1):213-26. PubMed ID: 2586750 [TBL] [Abstract][Full Text] [Related]
4. Does increased excitatory drive from the subthalamic nucleus contribute to dopaminergic neuronal death in Parkinson's disease? Luquin MR; Saldise L; Guillén J; Belzunegui S; San Sebastián W; Izal A; Garrido P; Vázquez M Exp Neurol; 2006 Oct; 201(2):407-15. PubMed ID: 16806173 [TBL] [Abstract][Full Text] [Related]
5. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus. Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR Neurosci Lett; 1985 Oct; 61(1-2):195-200. PubMed ID: 3878482 [TBL] [Abstract][Full Text] [Related]
6. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Schneider JS; Yuwiler A; Markham CH Brain Res; 1987 May; 411(1):144-50. PubMed ID: 2886180 [TBL] [Abstract][Full Text] [Related]
7. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man. Burns RS; Markey SP; Phillips JM; Chiueh CC Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980 [TBL] [Abstract][Full Text] [Related]
8. Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum. Herrero MT; Hirsch EC; Javoy-Agid F; Obeso JA; Agid Y Brain Res; 1993 Oct; 624(1-2):281-5. PubMed ID: 7902770 [TBL] [Abstract][Full Text] [Related]
9. Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey. Kitt CA; Cork LC; Eidelberg F; Joh TH; Price DL Neuroscience; 1986 Apr; 17(4):1089-103. PubMed ID: 2872615 [TBL] [Abstract][Full Text] [Related]
10. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease. Schwartzman RJ; Alexander GM Brain Res; 1985 Dec; 358(1-2):137-43. PubMed ID: 3878182 [TBL] [Abstract][Full Text] [Related]
12. Alterations in multiple tyrosine hydroxylase mRNAs in the substantia nigra, locus coeruleus and adrenal gland of MPTP-treated parkinsonian monkeys. Ohye T; Ichinose H; Ogawa M; Yoshida M; Nagatsu T Neurodegeneration; 1995 Mar; 4(1):81-5. PubMed ID: 7600187 [TBL] [Abstract][Full Text] [Related]
13. An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Goto K; Mochizuki H; Imai H; Akiyama H; Mizuno Y Brain Res; 1996 Jun; 724(1):125-8. PubMed ID: 8816266 [TBL] [Abstract][Full Text] [Related]
14. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake. Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR Neurosci Lett; 1986 Jan; 63(1):61-5. PubMed ID: 3485267 [TBL] [Abstract][Full Text] [Related]